INTRODUCTION
Integrins are acf-heterodimers and encompass different groups of adhesion receptors, characterized by one ,-subunit being associated with variable a-subunits [1, 2] . The platelet glycoprotein IIb/IIIa and the vitronectin receptor (VNR) are members of one of these groups, the cytoadhesin family [3, 4] , and share the same f-subunit [5] [6] [7] [8] . Platelet GPIIb/IIIa forms a Ca2+-dependent heterodimer on the platelet surface [9] , which serves, after platelet activation, as a receptor for fibrinogen, von Willebrand factor and fibronectin [10] . Endothelial cells synthesize a complex similar to GPIIb/IIIa [11] [12] [13] which interacts with vitronectin, fibrinogen and von Willebrand factor [14, 15] , and this complex has been shown to be identical with VNR [5] . The fl-subunit of these two cytoadhesins (GPIIIa or VNRfl) is a single-chain protein (100 kDa), whereas the two a-subunits, GPIIb and VNRa, are composed of a heavy (H) and a light (L) chain held together by disulphide bridges. Both a-subunits derive from a precursor form, the pro-a subunit, which contains the two polypeptidic chains [16] [17] [18] [19] . In previous studies we demonstrated that an early assembly of pro-a-subunits with the f-subunits is critical for the intracellular processing of the heterodimer and its exposure on the cell surface [20] . Once the pro-accf heterodimer is formed, carbohydrate processing proceeds differently for the aand the ,-subunits in both megakaryocytes and endothelial cells.
The oligosaccharide chains of the a-subunit are processed to the complex type in the Golgi system, whereas the f-subunit remains sensitive to endoglycosidase H (Endo H) in both cells [17] [18] .
Here we extended our studies on the biosynthetic pathways of cytoadhesins. Owing to controversial results already published [3, 5, 11, 21] 
Methods
Cell culture. Human megakaryocytes were obtained from chronic-myelogenous-leukaemic (CML) patients as described in [22, 17] . Human umbilical-vein endothelial (HUVE) cells were isolated by the method of Jaffe et al. [23] and cultured as described in [18] . HEL and LAMA-84 are two leukaemic cell lines that express GPIIb/IIIa [16, 24, 25] . Before metabolic labelling, HEL and LAMA-84 cells were induced for 3 days by 80 nM-PMA in RPMI 1640 containing 10 % (v/v) fetal-calf serum.
Metabolic labelling and immunoprecipitation. Metabolic labelling, cell lysis and immunoprecipitation were performed as previously described, by using Pansorbin to collect antigenantibody complexes [17, 18, 20] . When swainsonine was used, cells were preincubated overnight with swainsonine (2 4eg/ml) and this concentration was kept constant during the metabolic labelling. Samples were analysed by SDS/PAGE on 7-12 % linear-gradient gels [26] .
Washing and surface iodination of human platelets. Platelets were isolated and surface-labelled in the presence of carrier-free 1251 using the lactoperoxidase method [17] . Specificity of the antibodies used. Immunoprecipitations were performed with two mouse monoclonal antibodies, B2A and D12A, prepared in our laboratory from a BALB/c mouse immunized with purified GPIIIa and GPIIb respectively as previously described [17, 20] . In human megakaryocytes, when dissociation of the GPIIb/IIIa complexes was performed before immunoprecipitation by chelating Ca2+ with EDTA [27] , the anti-GPIIIa antibody B2A immunoprecipitated GPIIIa (100 kDa), whereas antibody D12A immunoprecipiated proGPIIb (130 kDa) and GPIIb H-chain [GPIIb(H)] (116 kDa) ( Fig. 1, lanes 1 and 2) , demonstrating the specificity of these antibodies for GPIIIa and GPIIb epitopes respectively. When these antibodies were used in combination, they immunoprecipitated under non-dissociating conditions pro-GPIIb, GPIIb(H) and GPIIIa (Fig. 1, lane 3) . Immunoprecipitations of HUVE-cell lysates were performed with the anti-GPIIIa antibody B2A, which immunoprecipitated VNRfl (100 kDa) and coimmunoprecipitated pro-VNRa (128 kDa) and VNRac H-chain [VNRa(H)] (118 kDa) (Fig. 1, lane 4) [18] .
Oligosaccharide digestion. 35S-labelled proteins were isolated by immunoprecipitation and separated on reducing 7-12 % linear-gradient gels [26] . Bands were excised from the gel, digested with Endo H (200 munits/ml; this concentration has proved optimal under our conditions) and analysed by SDS/PAGE on 7-120% linear-gradient gels as described in [17, 18] .
RESULTS AND DISCUSSION
Endo H-sensitivity of the different subunits of GPIIb/IIIa and
VNR
The Endo H-sensitivity of the mature forms of GPIIIa, VNRfl, GPIIb(H) and VNRa(H), was examined in cell lysates from 24 hmetabolically-labelled cells (human megakaryocytes, PMAtreated HEL and LAMA-84 cells, and HUVE cells) and surfacelabelled platelets. Endo H specifically removes not-fully-processed oligosaccharide chains, but does not remove complex-type carbohydrates [28] . In all these cellular systems, the mature forms of GPIIIa and VNRfl had a similar molecular mass of 100 kDa (Fig. 2, lanes 1-4 and 9 ), in agreement with their identical primary structures [6] [7] [8] . Consistent with our previous observations [17, 18] , GPIIIa and VNR,8 were sensitive to Endo H, since their molecular masses were decreased by approx. 10 kDa even after 24 h of metabolic labelling in megakaryocytes or endothelial cells (Fig. 2, lanes 5 and 8) (Fig. 2,  lanes 5-8 and 10) .
The Endo H-sensitivity of GPIIIa is in agreement (i) with its biochemical characterization [29, 30] , indicating that mannose residues represent 45 % of the sugars of GPIIIa, and (ii) with the fact that GPIIIa binds preferentially to concanavalin A [31] , suggesting the presence of N-linked oligosaccharide chains with branched mannose structure. Studies on the glycosylation of other integrins have already been published. Indeed, the ,-subunits of the leukocyte adhesion molecules [32] , the fibronectin receptor [33] and, surprisingly, the M21-melanoma-cell Arg-GlyAsp receptor immunoprecipitated by a monoclonal anti-GPIIIa antibody [21] , have been reported to be fully processed and Endo H-resistant. Thus the Endo H-sensitivity of the f8-subunit is a characteristic of the cytoadhesin family.
Processing of GPITb/IIIa and VNR a-and #i-subunits To characterize further the carbohydrate processing of the different subunits of GPIIb/IIIa and VNR, their sensitivity to Endo H was next examined in the presence of swainsonine. Swainsonine is an inhibitor of the Golgi mannosidase II, which blocks the formation of complex-type oligosaccharide chains and induces the formation of hybrid-type carbohydrates [34] that are sensitive to digestion by Endo H [35] [36] [37] . Swainsonine was used at 2 ,tg/ml, a concentration which has proved optimal under our conditions with respect to the viability of the cell, the overall protein synthesis (as measured by trichloroacetic acidprecipitable radioactivity) and the maximal inhibition of the amannosidase II (results not shown). Processing of GPIIb/IIIa and VNR a-and f-subunits was analysed in lysates from 8 hmetabolically-labelled megakaryocytes or HUVE cells. In native megakaryocytes, we immunoprecipated pro-GPIIb (130 kDa), GPIIb(H) (116 kDa), GPIIb L-chain [GPIIb(L)] (25 kDa) and GPIIIa (100 kDa) (Fig. 3, lane 1) as previously reported [17] . After treatment with swainsonine, the molecular masses of proGPIIb and GPIIIa were unmodified, whereas GPIIb(H) and GPIIb(L) migrated respectively at 114 and slightly below 25 kDa (Fig. 3, lane 2) . In native HUVE cells, we immunoprecipitated pro-VNRa (128 kDa), VNRa(H) (118 kDa), VNRa L-chain [VNRa(L)] (25 kDa) and VNR,f (100 kDa) (Fig. 4, lane 1) [18] .
In swainsonine-treated cells, only the molecular masses of VNRa(H) (116 kDa) and VNRa(L) (slightly below 25 kDa) were modified (Fig. 4, lane 2 ). After treatment with swainsonine, the change in molecular mass observed for GPIIb and VNRacc-and L-chains can be explained by the substitution of hybrid forms for complex ones [35] [36] [37] . In addition, the immunoprecipitation of GPIIb and VNRa H-and L-chains in swainsonine-treated cells indicated that, despite the inhibition of the carbohydrate processing by swainsonine, the proteolytic cleavage of pro-GPIIb and pro-VNRa still occurred. Thus complete processing of the carbohydrate moieties is not necessary for the proteolytic cleavage of the pro-a-subunits, and these two processing events would appear to occur independently. To investigate the Endo Hsensitivity of the a-and fl-subunits, bands were excised from the gel, treated with Endo H, and analysed by SDS/PAGE.
Processing of the a-subunits. As previously demonstrated, GPIIb(H) (116 kDa) (Fig. 3, lane 3) and VNRcc(H) (118 kDa) (Fig. 4, lane 3) were resistant to digestion with Endo H. In addition, this experiment showed that the L-chains of these asubunits, VNRa(L) and GPIIb(L) at 25 kDa, were not digested by Endo H (Fig. 3, lane 3 and Fig. 4, lane 3) , suggesting either that they were not glycosylated or that they shared complex oligosaccharides. Treatment of cells with swainsonine resulted in the synthesis of Endo H-sensitive ac-subunits: GPIIb(H) and Table 1 . Subunit molecular mass of, and oligosaccharide types in, GPIIb/IIIa and VNR Molecular masses of the glycosylated and deglycosylated forms were deduced from SDS/PAGE analysis [26] . The putative N-glycosylation sites were obtained from cDNA sequence analysis [6] [7] [8] [41] [42] [43] and biochemical characterization [40] . GPIIb(L) were decreased in molecular mass to respectively 103 and 22 kDa (Fig. 3, lane 4) , and VNRa(H) and VNRa(L) shifted respectively to 105 and 22 kDa (Fig. 4, lane 4) . Assuming an average molecular mass of 3 kDa for one complex oligosaccharide [38] , the a-subunit H-chains, GPIIb(H) and VNRa(H), were predicted to share four oligosaccharide chains of the complex type and to have a deglycosylated mass of respectively 103 and 105 kDa (see Table 1 ). In addition, these experiments provided the first evidence that their L-chains, GPIIb(L) and VNRa(L), were glycosylated by one complex-type carbohydrate chain. Results concerning GPIIb are consistent with its previously reported biochemical characterization [39, 40] , which indicated that GPIIb H-and L-chains were rich in sialic acid and galactose, two sugar residues known to compose oligosaccharide chains of the complex type [38] . Our findings establish that the putative N-glycosylation sites in megakaryocytic GPIIb given by the nucleotide sequence analysis [41, 42] and recent biochemical studies [40] , are all glycosylated by complex oligosaccharides (Table 1) . By contrast, the putative N-glycosylation points in VNRa [43] are not all glycosylated ( [17, 18] . These data suggest that the proteolytic cleavage does not occur in the endoplasmic reticulum. In the present study we show that all GPIIb carbohydrate chains are Endo H-resistant (Table 1) , in contrast with those of pro-GPIIb, which are all digested by Endo H [17] . This indicates that the acquisition of Endo H-resistance (which takes place after action of the N-acetylglucosamine transferase I and mannosidase II in the middle Golgi [45] ) and the proteolytic cleavage of the pro-GPIIb probably occur in the same compartment of the Golgi system. fl-Subunits of GPIIb/IIIa and VNR are differently glycosylated in megakaryocytes and endothelial cells. VNRJ from native and swainsonine-treated HUVE cells were decreased to 87 kDa after action of Endo H (Fig. 4, lanes 5 and 6) , showing that VNR/J contained not-fully-processed oligosaccharide chains only. By contrast, GPIIIa from swainsonine-treated megakaryocytes was more sensitive to digestion with Endo H than normal GPIIIa, as its molecular mass shifted to 87 kDa (Fig. 3, lane 6 ) instead of to 90 kDa as observed for normal GPIIIa (Fig. 3, lane 5) , demonstrating the presence of one Endo H-resistant oligosaccharide chain on normal GPIIIa. The molecular mass of 87 kDa for the deglycosylated fl-subunit is in agreement with our previous findings for the aglycosylated fl-subunit obtained after tunicamycin treatment [17, 18] . In addition, the complete digestion by Endo H of swainsonine-treated oligosaccharides confirms that Endo H was used under optimal conditions. These results for GPIIIa are supported by recent findings by Calvete et al. [46] . They obtained, by tryptic digestion of GPIIIa, two fragments of 23 and 80/70 kDa. The 23 kDa fragment, located in the N-terminal region, contained one putative N-glycosylation site [6] [7] [8] and was described as being enriched in sialic acid [46] , suggesting the presence of a complex carbohydrate chain. The five other putative N-glycosylation sites were located on the 80/70 kDa fragment (four of them in the cysteine-rich region of GPIIIa), whose oligosaccharide chains contained 50 % of mannose, and some sialic acid and galactose residues, suggesting the presence of high-mannose and/or hybrid-type oligosaccharide chains [38] . In addition, it has been suggested that processing is more extensive near the N-terminus of glycoproteins, where complex oligosaccharides are especially found, high-mannose types being located towards the C-terminus [47] . Taken together. these observations indicated that GPIIIa contains one complextype oligosaccharide chain located in its N-terminal region and four or five chains of the high-mannose or hybrid type in the C-terminal region (assuming the molecular mass of each high mannose chain to be 2.5 kDa [38] ). On VNR/1, all oligosaccharide side chains remain incompletely processed (Table 1) . Thus the same fl-subunit is differently processed in megakaryocytes and in endothelial cells. Numerous studies have demonstrated that a single glycoprotein may be differently glycosylated in different cell types, owing to the individual glycosylation machinery of a particular cell, the protein structure and the relative accessibility of the N-linked oligosaccharides to the processing enzymes (fox reviews, see [48, 49] ). In addition, it has already been reported foi the leukocyte adhesion receptors LFA-1 and Mac-1 that the quaternary structure of a heterodimer could influence the glycosylation of a polypeptide [50] . Thus the differential subunil association of GPIIIa and VNR, with GPIIb and VNRo may explain the difference in glycosylation of the N-terminai glycosylation site.
